Press release
Biosimilar and Follow On Biologics Market: Future market projections for forthcoming years
There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of these life saving drugs. However, these possibilities are opposed by some scientific challenges and unanswered questions.Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/biosimilar-and-follow-on-biologics-market.html
Some of the major factors driving the market are rising healthcare cost, expensive drugs and the ageing population. The major challenges faced by the follow-on biologics market are risk factors as it requires high investment and possibilities of failure during the drug development stages. The growth potential for biologics market is expected to be strong in the upcoming years as patents for numerous second generation therapeutic proteins slated for expiry between 2013 and 2019.
Many uncertainties surrounding the follow-on biologics are creating significant hurdles for companies to increase their business in the global market. The only way to success is to organize a cross disciplinary team with expertise in biological products, clinical development, regulatory affairs, and medical practices to watchfully plan a proper development strategy.
Request for Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=256
The research report on follow-on biologics market analyzes the global market size, and provides overview of market figures. It also studies the overall market growth rate and current advancements in industry. This report analyzes current trends, Porter’s five force analysis, and complete profiles of top industry players. It also provides a detailed review of micro and macro factors essential for existing market players and new entrants along with value chain analysis.
The key players dominating this market are 3SBio, Abbott, Abraxis BioScience, Alexion Pharmaceuticals, Amphastar Pharmaceuticals, Astra Zeneca, Avesta Biotherapeutics and Research (ABRPL), Avesthagen, Axicorp, Biogen Idec, Bristol-Myers Squibb, CCL Pharmaceuticals, CinnaGen, Cipla, Dr. Reddy’s Laboratories, Elan Corporation, Genentech, GlaxoSmithKline (GSK), Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Ranbaxy Laboratories, Sandoz, Zenotech, and others.
Pre book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=256<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilar and Follow On Biologics Market: Future market projections for forthcoming years here
News-ID: 875170 • Views: …
More Releases from Transparency Market Research
Global Hotels Market to Reach USD 2,694.9 Bn by 2036, Growing at 5.0% CAGR | Tra …
The global hotels market is entering a new phase of structured, technology-enabled growth, supported by strong recovery in travel demand and rising innovation across guest experience platforms. Valued at US$ 1,575.6 Bn in 2025, the market is projected to reach US$ 2,694.9 Bn by 2036, expanding at a CAGR of 5.0% from 2026 to 2036. Increasing digital innovation reshaping hotels and guest satisfaction, along with the resurgence of corporate travel…
Air Conditioning System Market to Reach US$ 247.5 Bn by 2036, Driven by Urbaniza …
The global air conditioning system market was valued at US$ 145.0 Bn in 2025 and is projected to reach US$ 247.5 Bn by 2036, expanding at a CAGR of 4.9% from 2026 to 2036. The market is poised for steady growth driven by rising global temperatures, rapid urbanization, increasing construction activities, expanding commercial infrastructure, and growing demand for energy-efficient cooling solutions.
Get Your Sample Report - Explore Exclusive Insights Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=436
Market…
Cowpeas Market to Reach USD 13.3 Billion by 2036, Advancing at 4.6% CAGR Amid Ri …
The Cowpeas Market is gaining strong momentum as global demand for plant-based protein, sustainable agriculture practices, and nutrient-rich food products continues to increase. Cowpeas, commonly known as black-eyed peas, are widely cultivated in tropical and subtropical regions due to their drought tolerance, low input requirements, and high nutritional value. As consumers increasingly prioritize healthy diets and environmentally friendly food sources, cowpeas are emerging as a vital crop supporting both food…
Oral Care Products Market to Reach US$ 127.7 Billion by 2036, Driven by Preventi …
The global oral care products market was valued at US$ 68.9 Billion in 2025 and is projected to reach US$ 127.7 Billion by 2036, expanding at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2036. This sustained growth reflects increasing consumer awareness of oral hygiene, rising disposable incomes, and the growing emphasis on preventive healthcare practices worldwide.
Oral care products, including toothpaste, toothbrushes, mouthwashes, dental floss, and advanced…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
